https://biotechmorning.com/news/thymus-tolerance-bio-tanabe-560-million-deal Biotech Morning en 2026-10-05T14:16:04.014Z The Organ Everyone Forgot Is Suddenly Worth $560 Million https://biotechmorning.com/news/ge-healthcare-sofie-biosciences-acquisition-cyclotrons Biotech Morning en 2026-10-05T14:15:21.103Z Why GE HealthCare Just Paid $945 Million for a Fleet of Cyclotrons https://biotechmorning.com/news/sanofi-regeneron-8-billion-immunology-deal Biotech Morning en 2026-10-05T14:14:34.948Z Pharma's Most Famous Couple Just Renewed Their Vows for $8 Billion https://biotechmorning.com/news/vaxcyte-vax-31-picks-fight-with-pfizer-vaccine Biotech Morning en 2026-10-05T14:13:52.589Z The Tiny Biotech That Just Picked a Fight With Pfizer's Biggest Vaccine https://biotechmorning.com/news/genentech-alector-al050-brain-delivery-deal Biotech Morning en 2026-10-05T14:13:04.516Z Why Genentech Just Bet $1.3 Billion on a Brain Delivery Trick https://biotechmorning.com/news/enveda-311m-series-e-natural-product-ai Biotech Morning en 2026-10-05T14:12:18.167Z The $311M Bet That Nature Is a Better Chemist Than We Are https://biotechmorning.com/news/novo-nordisk-denecimig-fda-delay-manufacturing Biotech Morning en 2026-10-05T14:11:29.070Z Novo Nordisk's Hemophilia Drug Was Ready. The Factory Wasn't. https://biotechmorning.com/news/bridgebio-bbp-418-cardiac-data-lgmd Biotech Morning en 2026-10-05T14:10:43.595Z The Rare Disease Drug That's Fixing Hearts Nobody Knew Were Breaking https://biotechmorning.com/news/europe-pharma-ceos-joint-letter-biotech-competitiveness Biotech Morning en 2026-10-05T14:09:54.741Z Europe's Pharma Giants Just Sent a 911 Call to Brussels https://biotechmorning.com/news/daiichi-sankyo-merck-adc-fda-withdrawal Biotech Morning en 2026-10-05T14:09:13.561Z The $4 Billion ADC Bet That Just Hit a Wall https://biotechmorning.com/news/rna-drug-sefaxersen-iga-nephropathy-phase-3 Biotech Morning en 2026-10-05T14:08:27.482Z The RNA Drug That Just Crashed Kidney Disease's Biggest Party https://biotechmorning.com/news/genmab-ovarian-cancer-adc-wont-quit Biotech Morning en 2026-10-04T14:12:52.114Z The Ovarian Cancer Drug That Won't Quit https://biotechmorning.com/news/zepbound-cheaper-vials-pricing Biotech Morning en 2026-10-04T14:12:06.387Z Zepbound Just Got a Price Tag That Changes Everything https://biotechmorning.com/news/cutaneous-lupus-litifilimab-52-week-data Biotech Morning en 2026-10-04T14:11:22.794Z The Skin Disease With Zero Approved Drugs Just Got a Contender https://biotechmorning.com/news/gsk-hutchmed-kras-deal Biotech Morning en 2026-10-04T14:10:41.415Z GSK Just Paid $110M for a Drug That Hasn't Treated a Single Patient Yet https://biotechmorning.com/news/lilly-ajax-therapeutics-jak-inhibitor-acquisition Biotech Morning en 2026-10-04T14:09:56.578Z Lilly Just Dropped $2.3 Billion on a Drug Class Everyone Gave Up On https://biotechmorning.com/news/genmab-8-billion-merus-acquisition Biotech Morning en 2026-10-04T14:09:10.715Z Genmab Just Wrote an $8 Billion Check for One Cancer Drug https://biotechmorning.com/news/shanghai-biotech-city-courting-western-pharma Biotech Morning en 2026-10-04T14:08:24.300Z Shanghai Built a Biotech City. Now It Wants Your Pipeline. https://biotechmorning.com/news/china-crashed-obesity-drug-party Biotech Morning en 2026-10-04T14:07:40.520Z China Just Crashed the Obesity Drug Party https://biotechmorning.com/news/fda-cder-office-china-clinical-trial-race Biotech Morning en 2026-10-04T14:06:52.606Z The FDA Just Declared a Space Race Against China